As cases of the omicron Covid variant steamroll through New York, the state government has turned saving lives into a matter of race, prioritizing non-white people to receive treatments. New York claims it is some sort of retribution for “longstanding systemic health and social inequities.”
Last week, New York’s Department of Health released a document to providers titled “Prioritization of Anti-SARS-CoV-2 Monoclonal Antibodies and Oral Antivirals for the Treatment of COVID-19 During Ties of Resource Limitations Introduction.”
The document lays out a hierarchy of sorts for who gets to receive the limited supplies of monoclonal antibody treatments and oral antiviral pills recently approved by the U.S. Food and Drug Administration under Emergency Use Authorization.
Trending: Biden 2024 Looks Increasingly Unlikely
In addition to individuals considered high-risk such as those who are